subscribeSubscribe
ANI focuses on data insights to ramp up Cortrophin

ANI focuses on data insights to ramp up Cortrophin
Karl Greenberg FIERCEPHARMA
24 Jun 2022
Share Share
U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid

U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid
J. Stempel REUTERS
04 Mar 2020
Share Share
Data on Acthar® Gel Therapy in Symptomatic Sarcoidosis Published

Data on Acthar® Gel Therapy in Symptomatic Sarcoidosis Published
PR NEWSWIRE
26 Nov 2019
Share Share
Mallinckrodt receives SEC subpoena over Acthar gel lawsuit

Mallinckrodt receives SEC subpoena over Acthar gel lawsuit
M.Maddipatla REUTER S
07 Nov 2019
Share Share
Mallinckrodt unloads its CDMO for $250M as potential liabilities mount

Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
Eric Palmer FIERCE PHARMA
10 Sep 2019
Share Share
Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount

Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount
K. Blankenship FIERCEPHARMA
07 Sep 2019
Share Share
Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk

Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk
Anna Smith PHARMATIMES
19 Jul 2019
Share Share
Medicare spent $2 billion for one drug as the manufacturer paid doctors millions

Medicare spent $2 billion for one drug as the manufacturer paid doctors millions
Wayne Drash CNN
02 Jul 2018
Share Share
Mallinckrodt to start ph 4 trial of H.P. Acthar gel for symptomatic sarcoidosis

Mallinckrodt to start ph 4 trial of H.P. Acthar gel for symptomatic sarcoidosis
PHARMABIZ
09 Oct 2017
Share Share
Mallinckrodt Enrolls First Patient in Phase 2B Trial of H.P. ActharGel for ALS

Mallinckrodt Enrolls First Patient in Phase 2B Trial of H.P. ActharGel for ALS
PR NEWSWIRE
14 Jun 2017
Share Share